Who owns OMEGA THERAPEUTICS INC?
- Ticker: OMGA
- CUSIP Number: 68217n105
Tip: Access positions for across all investors
Analyze quarterly positions in Omega Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Omega Therapeutics stock
Who bought or sold OMEGA THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Flagship Ventures Management | 29M | $88M | 0% | Dec 2023 |
|
State of Wisconsin Investment Board | 1.9M | $5.6M | 0% | Dec 2023 |
|
Vanguard Group | 1.5M | $4.5M | 2% | Dec 2023 |
|
Artal Group | 1.3M | $4.0M | -48% | Dec 2023 |
|
Blue Owl Capital Holdings | 1.1M | $3.2M | 100% | Dec 2023 |
|
Citigroup | 479k | $1.4M | 68482% | Dec 2023 |
|
72 Investment Holdings | 353k | $1.1M | 0% | Dec 2023 |
|
State Treasurer State Of Michigan | 314k | $1.1M | 0% | Mar 2024 |
|
Zacks Investment Management | 306k | $922k | 100% | Dec 2023 |
|
Jacobs Levy Equity Management | 298k | $898k | 100% | Dec 2023 |
|
Squarepoint Ops | 139k | $417k | 102% | Dec 2023 |
|
Bank of New York Mellon | 130k | $393k | 80% | Dec 2023 |
|
Point72 Asset Management | 129k | $390k | 0% | Dec 2023 |
|
683 Capital Management | 115k | $346k | -77% | Dec 2023 |
|
Charles Schwab Investment Management | 65k | $196k | 0% | Dec 2023 |
|
Bank of America Corporation | 59k | $177k | 239% | Dec 2023 |
|
Barclays | 47k | $142k | 162% | Dec 2023 |
|
Jane Street | 31k | $94k | 100% | Dec 2023 |
|
Two Sigma Investments | 30k | $91k | 100% | Dec 2023 |
|
UBS Group | 28k | $83k | 110% | Dec 2023 |
|
Millennium Management | 26k | $80k | -88% | Dec 2023 |
|
Amundi | 26k | $111k | 100% | Dec 2023 |
|
Rhumbline Advisers | 22k | $65k | -6% | Dec 2023 |
|
Wells Fargo & Company | 20k | $59k | 8% | Dec 2023 |
|
Murphy Pohlad Asset Management | 17k | $60k | 0% | Mar 2024 |
|
Jpmorgan Chase & Co | 16k | $48k | -39% | Dec 2023 |
|
New York State Common Retirement Fund | 14k | $42k | 0% | Dec 2023 |
|
Etfidea | 13k | $39k | 100% | Dec 2023 |
|
Goldman Sachs Group | 13k | $39k | -35% | Dec 2023 |
|
American International | 12k | $37k | 0% | Dec 2023 |
|
GW & Wade | 10k | $30k | 0% | Dec 2023 |
|
Royal Bank of Canada | 7.7k | $24k | 132% | Dec 2023 |
|
Amalgamated Bank | 3.5k | $10k | -7% | Dec 2023 |
|
Legal & General Group | 3.0k | $8.9k | 0% | Dec 2023 |
|
Simplex Trading | 2.5k | $7.0k | -73% | Dec 2023 |
|
Raleigh Capital Management | 2.1k | $6.3k | 100% | Dec 2023 |
|
Summit Investment Advisors | 2.0k | $6.1k | 0% | Dec 2023 |
|
Deutsche Bank Aktiengesellschaft | 1.5k | $4.6k | 0% | Dec 2023 |
|
Nelson, Van Denburg & Campbell Wealth Management | 1.2k | $3.5k | 100% | Dec 2023 |
|
Advisor Group Holdings | 852.00 | $2.6k | 100% | Dec 2023 |
|
Sandy Spring Bank | 750.00 | $2.3k | 200% | Dec 2023 |
|
Advisory Services Network | 638.00 | $1.9k | 100% | Dec 2023 |
|
Zurcher Kantonalbank | 299.00 | $899.990000 | -88% | Dec 2023 |
|
Hanson McClain Advisors | 268.00 | $807.001600 | 100% | Dec 2023 |
|
CWM | 2.00 | $0 | 100% | Mar 2024 |
|
Huntington National Bank | 1.00 | $3.000000 | 100% | Dec 2023 |
|
Who sold out of Omega Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Knoll Capital Management | Sep 2023 | 173k | $372k |
Oracle Investment Management | Sep 2023 | 50k | $108k |
Citadel Advisors | Sep 2023 | 46k | $99k |
Dimensional Fund Advisors | Sep 2023 | 20k | $42k |
Mirae Asset Global Investments | Sep 2023 | 15k | $32k |
McGlone Suttner Wealth Management | Dec 2023 | 6.6k | $20k |
Lazard Asset Management | Sep 2023 | 1.8k | $0 |
China Universal Asset Management | Sep 2023 | 1.4k | $3.0k |
Daiwa Securities Group | Sep 2023 | 139.00 | $0 |
NISA Investment Advisors | Sep 2023 | 31.00 | $67.000300 |